CD40 ligand-deficient T cells from X-linked hyper-IgM syndrome carriers have intrinsic priming capability
- PMID: 11801691
- DOI: 10.4049/jimmunol.168.3.1473
CD40 ligand-deficient T cells from X-linked hyper-IgM syndrome carriers have intrinsic priming capability
Abstract
Deficiency in CD40 ligand (CD40L) expression is associated with impaired T cell immunity in mouse models and in humans. Previous studies have indicated that this is due to the failure of induction of extrinsic costimulatory molecules. However, other studies have suggested that CD40L is an intrinsic costimulatory molecule. The X-linked hyper-IgM syndrome (XHIM) is a primary immunodeficiency caused by mutations in CD40L, resulting in impaired Ab production and T cell immunity. CD4+ T cells from female carriers of XHIM express a variable degree of normal CD40L based on random X chromosome inactivation. We have examined T cells from XHIM carriers to investigate whether CD40L supports T cell function by acting as an intrinsic costimulator or by induction of other costimulatory molecules by examining coexpression of CD40L and markers of T lymphocyte priming. These carriers provide a unique model for comparison of CD40L-expressing and -nonexpressing lymphocytes in that all factors, including immunological experience, are equivalent between the two populations. Our results show that compared with CD40L-deficient T cells, T cells that express CD40L normally have a minimal advantage in becoming primed, as defined by CD45 RO isoform expression and production of IFN-gamma and TNF-alpha. Conversely, CD40L-deficient T lymphocytes clearly were capable of becoming primed as defined by the same parameters. These findings imply that the intrinsic costimulatory activity of CD40L is not required for attaining primed status, and that CD40L primarily supports T cell function by inducing extrinsic factors that can be shared by CD40L-deficient cells.
Similar articles
-
Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome.Blood. 1998 Oct 1;92(7):2421-34. Blood. 1998. PMID: 9746782
-
CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.Immunol Res. 2001;24(3):311-24. doi: 10.1385/IR:24:3:311. Immunol Res. 2001. PMID: 11817328 Review.
-
CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization.Eur J Immunol. 1999 Jan;29(1):367-73. doi: 10.1002/(SICI)1521-4141(199901)29:01<367::AID-IMMU367>3.0.CO;2-4. Eur J Immunol. 1999. PMID: 9933119
-
Development of a rapid whole blood flow cytometry procedure for the diagnosis of X-linked hyper-IgM syndrome patients and carriers.Clin Immunol Immunopathol. 1997 Nov;85(2):172-81. doi: 10.1006/clin.1997.4422. Clin Immunol Immunopathol. 1997. PMID: 9344700
-
Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)".Immunol Rev. 1994 Apr;138:39-59. doi: 10.1111/j.1600-065x.1994.tb00846.x. Immunol Rev. 1994. PMID: 7915248 Review.
Cited by
-
Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity.J Neuroinflammation. 2021 Oct 26;18(1):244. doi: 10.1186/s12974-021-02298-6. J Neuroinflammation. 2021. PMID: 34702288 Free PMC article.
-
Loss of CD154 impairs the Th2 extrafollicular plasma cell response but not early T cell proliferation and interleukin-4 induction.Immunology. 2004 Oct;113(2):187-93. doi: 10.1111/j.1365-2567.2004.01951.x. Immunology. 2004. PMID: 15379979 Free PMC article.
-
T Follicular Regulatory Cell Suppression of T Follicular Helper Cell Function Is Context-Dependent in vitro.Front Immunol. 2020 Apr 17;11:637. doi: 10.3389/fimmu.2020.00637. eCollection 2020. Front Immunol. 2020. PMID: 32362895 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous